OXGENE

Be First

In the Race

To deliver breakthrough
cell & gene therapies

ACCELERATE YOUR SUCCESS

When your scientific success means being first; to discover, to publish, to reach the clinic, OXGENE, helps pioneering companies accelerate the discovery and biomanufacture of their CAR-T / Cell Therapies and Gene Therapies; to be first to deliver these breakthrough therapeutics to the patients who need them.

Advanced

Cell Therapy
Solutions

Advanced

Gene Therapy
Solutions

SUPPORTING A PIONEERING COMMUNITY

We provide pioneering companies with advanced technology and service solutions to accelerate the transition between laboratory research and clinical manufacture.

OUR VISION

Cutting edge science with purpose.

Invention and innovation to advance and improve the development and delivery of cell and gene therapies.

OUR MISSION

To get the benefits of our innovations to the patients who need them.

To demonstrate the technical and commercial viability of our innovations, and to integrate them into manufacturing platforms that will provide large scale, global market access.

WuXi

WuXi Advanced Therapies

INTEGRATED GMP
MANUFACTURING AND TESTING

SUPPORTING A PIONEERING COMMUNITY

We provide pioneers with advanced technology and service solutions to
accelerate the transition between laboratory research and clinical
manufacture.

ScientificSuccess Stories

05 Jan 2021

OXGENE - Cell line development

OXGENE’s team of cell line engineering experts design a strategy and use our optimised workflow and high throughput screening platform to maximise...

12 Jan 2021

OXGENE - iPSCs Infographic

Human induced pluripotent stem cells (iPSCs) are adult cells that have been transformed using a combination of transcription factors to...

18 Mar 2021

OXGENE - TESSA Infographic

The challenge of scalable AAV manufacture for gene therapies, and how to overcome it. Gene therapies offer enormous promise for the treatment of...

26 Oct 2021

OXGENE Case Study - TiCARos

TiCARos Therapeutics has leveraged the expertise of their team of immunologists from Seoul National University, College of Medicine to develop a...

15 Feb 2022

OXGENE Case Study - Carisma

Cancer immunotherapies aim to harness the immune system to fight tumours. Carisma Therapeutics is taking a novel approach to cancer immunotherapy by...

OUR MISSION IS TO ACCELERATE SUCCESS

07 Mar 2022

Launch of TESSA™ Technology

WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies TESSA™ technology provides a...

EMA GMP Certification for new testing facility image

EMA GMP Certification for new testing facility

WuXi AppTec acquire OXGENE image

WuXi AppTec acquire OXGENE

Accelerating gene therapy development image

Accelerating gene therapy development

WuXi ATU and Wugen Announce Manufacturing Partnership image

WuXi ATU and Wugen Announce Manufacturing Partnership

BE FIRST in the race to deliver
breakthrough Cell & Gene Therapies

Our Awards

Our pioneering spirit drives our success. We're honoured to be recognised in the following awards.

TheScientist Top 10 2020

Tech Track 100 2020

Deloitte Fast 50 2020

Top 100 Britain

Scrip Awards 2019

×

‹ › ×